CD8A and neoplasm: However, in 2018, a study published in Nature reported that the direct distinction between TSTs and bystander T cells within TILs was CD39 expression, which demonstrated that CD39+CD8+ TILs were a population that could recognize tumor neoantigens specifically (7).